HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

OTC Vaniqa Could Surface By Early 2005

This article was originally published in The Rose Sheet

Executive Summary

Women First HealthCare may explore Rx-to-OTC switch opportunities forVaniqa facial hair growth retardation cream as early as 2004, the firm stated

You may also be interested in...



Gillette Mach3 Turbo Revs Up Q2 Blade And Razor Sales

Gillette blade and razor sales jumped 10% to $884 mil. in the second quarter led by the Mach3 Turbo shaving system, VP-Investor Relations Chris Jakubik said during the company's second quarter financial report July 23

Gillette Mach3 Turbo Revs Up Q2 Blade And Razor Sales

Gillette blade and razor sales jumped 10% to $884 mil. in the second quarter led by the Mach3 Turbo shaving system, VP-Investor Relations Chris Jakubik said during the company's second quarter financial report July 23

Clairol $50 Mil. Marketing Boost Part Of P&G Blueprint For Growth

Procter & Gamble plans to increase marketing spending on Clairol by approximately $50 mil. within its first year of acquiring the hair care business to "restore competitive marketing," President and CEO A.G. Lafley said during a May 21 analyst meeting outlining plans for the purchase.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS010418

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel